Table II.
Parameter | Direct sequencing | Scorpion-ARMS | Pyrosequencing | Luminex xMAP |
---|---|---|---|---|
Detected cases (%) | 68 (93.2%) | 71 (97.3%) | 70 (95.9%) | 69 (94.5%) |
Wild-type KRAS (%) | 40 (54.8%) | 42 (57.5%) | 41 (56.2%) | 38 (52.1%) |
Mutated KRAS (%) | 28 (38.4%) | 29 (39.7%) | 29 (39.7%) | 31 (42.5%) |
Undetectable cases (%) | 5 (6.8%) | 2 (2.7%) | 3 (4.1%) | 4 (5.5%) |
KRAS, Kirsten rat sarcoma viral oncogene homolog.